4526 - 4550 of 6451 Results
Title
Year
-
OPENTitle: LRRK2 -associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterizationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 2Start Page: fcaf103End Page: fcaf103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf103Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf103/62298367/fcaf103.pdfCitation Count: 15
-
OPENTitle: Levodopa-induced dyskinesia in Parkinson's disease: Insights from cross-cohort prognostic analysis using machine learningJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 126Issue #:Start Page: 107054End Page: 107054Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107054Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107054Citation Count: 6
-
OPENTitle: A role for the subthalamic nucleus in aversive learningJournal Name: Cell ReportsPublisher: Elsevier BVVol: 42Issue #: 11Start Page: 113328End Page: 113328Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2023.113328Best OA location URL: http://www.cell.com/article/S2211124723013402/pdfCitation Count: 20
-
OPENTitle: Unraveling the Biologic Basis for Domain-Specific Cognitive DeclineJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 25Issue #: 7Start Page: 741End Page: 743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5870749Citation Count: 1
-
OPENTitle: Use of β-adrenoreceptor drugs and Parkinson’s disease incidence in women from the French E3N cohort studyJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 4Start Page: 789End Page: 804Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251330993Best OA location URL: https://doi.org/10.1177/1877718x251330993Citation Count: 1
-
OPENTitle: AI-Validated Brain Targeted mRNA Lipid Nanoparticles with Neuronal TropismJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 19Issue #: 41Start Page: 36106End Page: 36128Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acsnano.4c15013Best OA location URL: https://doi.org/10.1021/acsnano.4c15013Citation Count: 23
-
OPENTitle: Resolving inter-regional communication capacity in the human connectomeJournal Name: Network NeurosciencePublisher: MIT PressVol: 7Issue #: 3Start Page: 1051End Page: 1079Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1162/netn_a_00318Best OA location URL: https://direct.mit.edu/netn/article-pdf/doi/10.1162/netn_a_00318/2078941/netn_a_00318.pdfCitation Count: 5
-
OPENTitle: In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy BiomarkerJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 22Start Page: 16445End Page: 16445Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms242216445Best OA location URL: https://www.mdpi.com/1422-0067/24/22/16445/pdf?version=1700208971Citation Count: 5
-
OPENTitle: Dopaminergic Axon Tracts Within a Hyaluronic Acid Hydrogel Encasement to Restore the Nigrostriatal PathwayJournal Name: Advanced Healthcare MaterialsPublisher: WileyVol: 14Issue #: 2Start Page: e2402997End Page: e2402997Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/adhm.202402997Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/adhm.202402997Citation Count: 6
-
OPENTitle: The landscape of rare genetic variation associated with inflammatory bowel disease and Parkinson’s disease comorbidityJournal Name: Genome MedicinePublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page: 66End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13073-024-01335-2Best OA location URL: https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-024-01335-2Citation Count: 20
-
OPENTitle: Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathiesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 5109End Page: 5109Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49258-1Best OA location URL: https://www.nature.com/articles/s41467-024-49258-1.pdfCitation Count: 28
-
OPENTitle: SynBot is an open-source image analysis software for automated quantification of synapsesJournal Name: Cell Reports MethodsPublisher: Elsevier BVVol: 4Issue #: 9Start Page: 100861End Page: 100861Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100861Best OA location URL: https://doi.org/10.1016/j.crmeth.2024.100861Citation Count: 28
-
OPENTitle: Liganded magnetic nanoparticles for magnetic resonance imaging of α-synucleinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 88End Page: 88Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00918-zBest OA location URL: https://www.nature.com/articles/s41531-025-00918-z.pdfCitation Count: 1
- Microinvasive Probes for Monitoring Electrical and Chemical Neural Activity in Nonhuman Primates2025OPENTitle: Microinvasive Probes for Monitoring Electrical and Chemical Neural Activity in Nonhuman PrimatesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 16Issue #: 12Start Page: 2237End Page: 2247Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.5c00071Best OA location URL: https://doi.org/10.1021/acschemneuro.5c00071Citation Count: 1
- Wearables for Parkinson's: Fast‐Paced toward Novel Outcome Measures2023OPENTitle: Wearables for Parkinson's: Fast‐Paced toward Novel Outcome MeasuresJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 11Start Page: 1988End Page: 1989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29608Citation Count: 1
-
OPENTitle: Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+ T cells, and M1 macrophagesJournal Name: Journal for ImmunoTherapy of CancerPublisher: BMJVol: 8Issue #: 2Start Page: e001617End Page: e001617Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1136/jitc-2020-001617Best OA location URL: https://jitc.bmj.com/content/jitc/8/2/e001617.full.pdfCitation Count: 47
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 89
-
OPENTitle: Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin studyJournal Name: Journal of NeurochemistryPublisher: WileyVol: 149Issue #: 1Start Page: 126End Page: 138Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/jnc.14569Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14569Citation Count: 55
-
OPENTitle: Herpesvirus genome integration in whole‐genome sequences of dementia and control cohortsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 22Issue #: 3Start Page: e71047End Page: e71047Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.71047Best OA location URL: https://doi.org/10.1002/alz.71047Citation Count: 0
-
OPENTitle: Pre-symptomatic Parkinson’s disease blood test quantifying repetitive sequence motifs in transfer RNA fragmentsJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 5Issue #: 5Start Page: 868End Page: 882Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s43587-025-00851-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12092246Citation Count: 23
-
OPENTitle: Genomewide Association Studies of LRRK2 Modifiers of Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: 1Start Page: 76End Page: 88Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.26094Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26094Citation Count: 49
-
OPENTitle: Understanding the role of genetic variability in LRRK2 in Indian populationJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 496End Page: 505Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27558Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8985845Citation Count: 16
-
OPENTitle: Reply: Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson’s disease and BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 2Start Page: e16End Page: e16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa369Best OA location URL: https://academic.oup.com/brain/article-pdf/144/2/e16/36454303/awaa369.pdfCitation Count: 1
-
OPENTitle: Overcoming obstacles to repurposing for neurodegenerative diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 1Issue #: 7Start Page: 512End Page: 518Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.76Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.76Citation Count: 62
-
OPENTitle: Breakthrough News in Adenoviral Vector‐Mediated AADC Gene Therapy: Lessons from the Success in AADC Deficiency and Possible Future ApplicationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 737End Page: 738Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13503Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9346230Citation Count: 1